Search results
AstraZeneca slips after Imfinzi falls short in cancer trial
Investing.com via Yahoo Singapore Finance· 2 years agoBy Geoffrey Smith Investing.com -- AstraZeneca (LON:AZN) stock slipped in morning trading in London on Monday, after the U.K.-Swedish pharma company said its Imfinzi drug had failed to reach ...